ASCANI, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 5.495
EU - Europa 4.403
AS - Asia 4.042
SA - Sud America 805
AF - Africa 114
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 14.867
Nazione #
US - Stati Uniti d'America 5.341
SG - Singapore 2.047
IE - Irlanda 738
SE - Svezia 720
BR - Brasile 641
RU - Federazione Russa 635
IT - Italia 608
UA - Ucraina 524
CN - Cina 470
HK - Hong Kong 419
VN - Vietnam 388
DE - Germania 271
FR - Francia 255
FI - Finlandia 232
KR - Corea 175
GB - Regno Unito 164
IN - India 98
TR - Turchia 97
CA - Canada 86
BD - Bangladesh 65
AR - Argentina 54
PL - Polonia 51
IQ - Iraq 44
ZA - Sudafrica 39
AT - Austria 38
MX - Messico 38
CH - Svizzera 36
PK - Pakistan 33
UZ - Uzbekistan 31
CZ - Repubblica Ceca 27
JP - Giappone 26
EC - Ecuador 25
VE - Venezuela 23
ID - Indonesia 22
NL - Olanda 22
BE - Belgio 20
CO - Colombia 18
ES - Italia 17
MA - Marocco 16
SA - Arabia Saudita 16
LB - Libano 15
PH - Filippine 15
TN - Tunisia 13
AE - Emirati Arabi Uniti 11
CL - Cile 11
EG - Egitto 11
PE - Perù 11
PY - Paraguay 11
GR - Grecia 9
MY - Malesia 9
CR - Costa Rica 8
JO - Giordania 7
OM - Oman 7
AZ - Azerbaigian 6
ET - Etiopia 6
KZ - Kazakistan 6
RO - Romania 6
SN - Senegal 6
UY - Uruguay 6
IR - Iran 5
KG - Kirghizistan 5
LT - Lituania 5
BO - Bolivia 4
DZ - Algeria 4
EU - Europa 4
HN - Honduras 4
KE - Kenya 4
NP - Nepal 4
PA - Panama 4
PT - Portogallo 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
IL - Israele 3
JM - Giamaica 3
LA - Repubblica Popolare Democratica del Laos 3
PS - Palestinian Territory 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GP - Guadalupe 2
ME - Montenegro 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TG - Togo 2
AO - Angola 1
BF - Burkina Faso 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CI - Costa d'Avorio 1
CM - Camerun 1
CV - Capo Verde 1
DK - Danimarca 1
EE - Estonia 1
Totale 14.846
Città #
Singapore 1.440
Dublin 736
Chandler 664
San Jose 509
Hong Kong 419
Ashburn 394
San Mateo 371
Boardman 283
Jacksonville 262
Moscow 239
Santa Clara 213
Perugia 209
Altamura 187
Wilmington 187
Medford 181
Princeton 177
Dong Ket 174
Seoul 171
Lauterbourg 166
Lawrence 153
Ann Arbor 132
Beijing 121
Munich 106
Andover 85
Los Angeles 79
Ho Chi Minh City 73
New York 72
Helsinki 61
Izmir 61
Piscataway 61
Des Moines 56
Ottawa 52
The Dalles 52
Saint Petersburg 50
São Paulo 47
Hanoi 46
Turku 44
Houston 41
Norwalk 38
Orem 35
Woodbridge 35
San Paolo di Civitate 30
Falls Church 28
Warsaw 28
Dallas 27
Belo Horizonte 26
Tokyo 24
Johannesburg 23
Nuremberg 23
Montreal 22
Brooklyn 21
Baghdad 20
Chennai 20
Chicago 20
Brussels 19
Atlanta 18
Frankfurt am Main 18
Rio de Janeiro 18
Council Bluffs 17
London 17
Boston 15
Denver 15
Rome 15
Redwood City 14
Ankara 13
Mexico City 13
Stockholm 13
Brno 12
Auburn Hills 11
Curitiba 11
Lahore 11
Poplar 11
Redmond 11
Tashkent 11
Vienna 11
Cape Town 10
Dearborn 10
Olomouc 10
Phoenix 10
Shanghai 10
Tianjin 10
Falkenstein 9
Haiphong 9
Kraków 9
Milan 9
New Delhi 9
San Francisco 9
Brasília 8
Columbus 8
Den Haag 8
Lausanne 8
Manchester 8
Nova Iguaçu 8
Porto Alegre 8
Quito 8
Santiago 8
Seattle 8
Vicenza 8
Amsterdam 7
Campinas 7
Totale 9.304
Nome #
Anaplastic lymphoma kinase expression as a marker of malignancy. Application to a case of anaplastic large cell lymphoma with huge granulomatous reaction. 145
The expression pattern of c-mpl in megakaryocytes correlates with thrombotic risk in essential thrombocythemia. 144
Clinical efficacy and antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia. A pilot study. 144
Acute leukaemia immunophenotyping in bone-marrow routine sections. 141
Aspetti clinici dei tumori neuroendocrini 139
Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma 139
New somatic TERT promoter variants enhance the Telomerase activity in Glioblastoma 139
INTRAPLEURAL TIGECYCLINE INDUCES PLEURODESIS IN RABBIT 136
Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions. 132
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia 128
CD10 is frequently expressed in classical seminomas. 122
Identification of two independent clones underlying the co-existence of myelodysplastic syndrome with excess of blasts type 2 and isolated 5q- and smoldering multiple myeloma 121
Clear cell proliferation of the lung with lymphangioleiomyomatosis-like change. 119
Diffuse large B-cell lymphoma: one or more entities? Present controversies and possible tools for its subclassification 119
Neuroendocrine prevalence in thymic tumors. 118
Granulocytic sarcoma of main biliary ducts. 117
Tumori neuroendocrini toracici ben differenziati: la corretta gestione clinica 116
High-Risk Clonal Hematopoiesis as the Origin of AITL and NPM1-Mutated AML 116
Critical commentary to: bone marrow extracellular large geometric crystal in IgG/L MGUS. 115
Erythrophagocytosis by neoplastic cells in a patient with myelodysplastic syndrome. 115
Pathologist's point of view (I): indolent lymphomas. 115
CD27 distinguishes two phases in bone marrow infiltration of splenic marginal zone lymphoma. 115
Tumorlets, multicentric carcinoids, lymph-nodal metastases, and long-term behavior in bronchial carcinoids 115
Aggressive lymphomas: a convenient concept or an anatomo-pathological reality? 114
Antigen retrieval techniques in immunohistochemistry: comparison of different methods 112
Co-existence of Philadelphia chromosome positive acute megakaryoblastic and B-lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemia. 111
Well differentiated thoracic neuroendocrine tumors: clinical management and therapy 111
Primary bone lymphoma: experience with 52 patients. 109
Cytogenetic/mutation profile of chronic lymphocytic leukemia/malignant melanoma collision tumors of the skin 109
Tumori Neuroendocrini del Polmone, aspetti medici 108
Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease 108
Constant Activation of the RAF-MEK-ERK Pathway As a Diagnostic and Therapeutic Target in Hairy Cell Leukemia. 108
Blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia: a shared clonal origin 108
Primay large B-cell lymphoma (PLBCL) of the retroperitoneum: a heterogeneous group of neoplasms, some of which mimic PLBCL of the mediastinum. 107
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. 107
Ibrutinib treatment of a patient with relapsing chronic lymphocytic leukemia and sustained remission of Richter syndrome 107
Intravascular NK/T-cell lymphoma, Epstein-Barr virus positive with multiorgan involvement: A clinical dilemma 107
Dissecting Clonal Hematopoiesis in Tissues of Classical Hodgkin Lymphoma Patients 107
Myeloid sarcoma of liver: an unusual cause of jaundice. Report of three cases and review of literature. 106
Prevalence of the neuroendocrine phenotype in thymus neoplasms. 106
Pathobiology of primary mediastinal B-cell lymphoma. 104
Neuroendocrine Features Of Well Differentiated Human Neuroendocrine Lung Tumors - Atti XXII Congresso Nazionale Società Italiana Endocrino Chirurgia 104
Richter's transformation in the heart 104
Robotic treatment of oligometastatic kidney tumor with synchronous pancreatic metastasis: Case report and review of the literature 104
Expression of B-lymphocyte-associated transcription factors in human T-cell neoplasms. 103
Could thymomectomy be a reasonable option for non-myasthenic thymoma patients? 103
An Italian Case of Disseminated Histoplasmosis Associated with HIV 102
High-throughput tissue microarray analysis of G1-c alterations in classical Hodgkin's lymphoma indicates overexpression of cyclin E1. 101
Gemcitabine treatmnet in pretreated cutaneous T-cell lymphoma: experience in 44 patients. 98
Prognostic significance of CD44 expression in diffuse large B-cell lymphoma of activated and germinal center B-cell-like types: a tissue microarray analysis of 90 cases. 98
Successful resumption of epoetin alfa after rituximab treatment in a patient with pure red cell aplasia 98
Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia 96
Anaplastic lymphoma kinase-positive large B-cell lymphoma: Description of a case with an unexpected clinical outcome 96
Efficacy of rituximab in hairy cell leukemia treatment. 95
Prevalenza del fenotipo neuroendocrino nelle neoplasie del timo 95
Constant activation of the RAF-MEK-ERK pathway as a diagnostic and therapeutic target in hairy cell leukemia. 95
Atypical intrasinusoidal bone marrow involvement by hairy cell leukemia 95
Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML 95
Prognostic Significance of Pulmonary Multifocal Neuroendocrine Proliferation With Typical Carcinoid 94
Association between histologic type of polyp and carcinoma in the stomach 94
A BRAF-mutated case of hairy cell leukaemia lacking Annexin-A1 expression 94
Hhv8-positive castleman disease and in situ mantle cell neoplasia within dermatopathic lymphadenitis, in longstanding psoriasis 94
Identification of a novel t(1;9)(q11;q34) in acute myelocytic leukemia. 93
From chronic lymphocytic leukemia to Hodgkin's disease: a case of prognostically favorable transformation. 93
Surgical treatment of neuroendocrine tumors of the lung. 2nd EACTS/ESTS Joint Meeting. 93
Fibrin-associated large B-cell lymphoma: first case report within a cerebral artery aneurysm and literature review 92
Case Report: Contrasting BCL2 Upregulation With Venetoclax in a Case of Refractory Lymphomatoid Papulosis and Progressive Chronic Lymphocytic Leukemia 92
CD123 Is Consistently Expressed on NPM1-Mutated AML Cells 91
Hodgkin's lymphoma: the patologist's viewpoint. 91
Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma 91
Flower cells of tropical descent: a challenging case of adult T-cell leukemia/lymphoma 91
Rapid and sustained response of an intra- and extracranial large cell lymphoma mass to liposomal intrathecal Ara-C and R-MegaCEOP systemic chemotherapy. 90
Asymptomatic Infiltrated Erythematous Skin Patch on the Breast 89
Primary histiocytic sarcoma presenting as diffuse leptomeningeal disease: Case description and review of the literature 89
T-cell prolymphocytic leukemia: does the expression of CD8+ phenotype justify the identification of a new subtype? Description of two cases and review of the literature. 87
CD4-negative variant of CD4+/CD56+ hematodermic neoplasm: description of three cases. 86
Gene expression analysis of peripheral T-cell lymphoma not otherwise specified reveals the existance of two subgroups related to different cellular counterparts and recurrent PDGFRA deregulation 85
Diffuse large B-cell lymphoma (DLBCL), anaplastic variant. report on a problematic case primarily arising in the stomach 85
In vitro” and “in vivo” somatostatin receptor subtype expression in well differentiated lung neuroendocrine tumors ( typical anc atypical brochial carcinoid) 85
A tricky and rare cause of pulmonary eosinophilia: Myeloid/lymphoid neoplasm with eosinophilia and rearrangement of PDGFRA 85
Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by 67 Gallium scan in 50 patients. 84
IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas. 84
Anaplastic large cell lymphoma: a concept reviewed 84
Nodal marginal zone lymphoma associated with monoclonal light-chain and heavy-chain deposition disease. 83
Gene expression analysis of peripheral T-cell lymphoma not otherwise specified reveals the existance of two subgroups related to different cellular counterparts. 83
Beta-HCG aberrant expression in primary mediastinal large B-cell lymphoma. 83
MicroRNAs sequencing unveils distinct molecular subgroups of plasmablastic lymphoma 83
Immunohistochemical surrogates for genetic alterations of CCDN1, PML, ALK, and NPM1 genes in lymphomas and acute myeloid leukemia. 82
Extracavitary primary effusion lymphoma in a post-transplantation patient 82
The association between non-Hodgkin lymphoma and renal cell carcinoma in an HIV-positive patient: Clinico-pathological features and pathogenic implications 80
One disease, two faces: clonally-related AML and MPDCP with skin involvement 78
Localized Crystal-Storing Histiocytosis Involving Lower Rectum 78
CD5-Negative Primary Mantle Cell Lymphoma Presenting with a Bilateral Conjunctival Mass: A Potential Diagnostic Pitfall 76
Correction to: A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit: A position paper from the Italian Group of Haematopathology (G.I.E.) (Virchows Archiv, (2019), 475, 4, (513-518), 10.1007/s00428-019-02637-2) 76
Mast Cell Leukemia: An Update with a Practical Review 75
Uncommon lymphoplasmacytic lymphoma with IgA paraproteinemia: a challenging clinical diagnosis solved by MYD88 mutation analysis. 75
A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit: A position paper from the Italian Group of Haematopathology (G.I.E.) 75
Atypical mycobacteria diagnosed by bone marrow biopsy in an HIV-positive patient 75
New classification of acute myeloid leukemia and precursor-related neoplasms: changes and unsolved issues. 74
Marker expression in peripheral T-cell lymphorna unspecified: Proposal of a clinical-pathologic prognostic score 73
Totale 10.108
Categoria #
all - tutte 68.492
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.492


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021396 0 0 0 0 0 0 0 0 0 78 108 210
2021/20221.553 56 311 39 142 53 28 13 408 19 44 226 214
2022/20232.421 190 479 31 161 190 260 3 97 925 3 63 19
2023/2024866 75 81 58 12 3 10 187 6 79 39 152 164
2024/20252.503 60 247 47 107 330 126 123 197 551 153 321 241
2025/20264.991 408 334 310 619 732 468 877 293 577 373 0 0
Totale 15.529